Mereo Biopharma Group PLC
NASDAQ:MREO

Watchlist Manager
Mereo Biopharma Group PLC Logo
Mereo Biopharma Group PLC
NASDAQ:MREO
Watchlist
Price: 3.72 USD 1.09% Market Closed
Market Cap: 572.3m USD
Have any thoughts about
Mereo Biopharma Group PLC?
Write Note

P/S
Price to Sales

45.7
Current
4.4
Median
7.7
Industry
Higher than median
Higher than industry value

Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.

P/S
45.7
=
Market Cap
572.3m USD
/
Revenue
10m GBP
All Countries
Close

P/S Forward Multiples

Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/S
39.2
2-Years Forward
P/S
35.8
3-Years Forward
P/S
6.6

See Also

Discover More